#Sweden #Stockholm #SciBase #NIH study #EIS Technology

Introduction

SciBase, a prominent player in dermatology technology, has recently made headlines with its Electrical Impedance Spectroscopy (EIS) being designated as a primary endpoint for an important study led by the National Institutes of Health (NIH). The initiative aims to investigate the relationship between environmental exposure and skin barrier health, utilizing the company’s innovative Nevisense platform.

The THREAT Study

The NIH has collaborated with the Swiss Institute of Allergy and Asthma Research (SIAF) to launch a study named THREAT (Testing Harms Related to Exposure to Allergenic Toxins). This research will explore how various common environmental factors influence skin health. Specifically, the study will involve 80 healthy volunteers who will be exposed to different types of products, including those containing sodium lauryl sulfate (SLS) as well as alternatives free from synthetic materials.

The fundamental goal is to ascertain how these exposures affect skin barrier function. To measure such effects, researchers will focus on skin impedance—a key feature assessed using SciBase's state-of-the-art EIS technology. The method measures how easily electrical signals pass through the skin, providing insights into its functional status and health.

Key Aspects of the Study

1. Innovative Endpoint: The selection of EIS technology as the main measurement tool signifies a noteworthy endorsement of SciBase’s capabilities in capturing complex dermatological data.
2. Diverse Exposures: Participants will be systematically exposed to a range of common skin irritants and allergens, including detergents and synthetic textiles, affording a comprehensive overview of daily environmental impacts on skin health.
3. Multifaceted Monitoring: Alongside EIS, the study will also track various biomarkers, including molecular, microbiome, and genomic indicators—the combination of which could yield a multidimensional understanding of skin response to environmental factors.

Significance of EIS Technology

The use of EIS as a primary endpoint positions it as an objective, scientific method for evaluating skin barrier function, laying the groundwork for its application not only in dermatology but also in cosmetic and skincare product development. As the study progresses, the insights gleaned could reshape our understanding of skin health management in light of contemporary environmental challenges.

Expert Insights

Pia Renaudin, the CEO of SciBase, expressed enthusiasm about the study, stating, "We are proud that Nevisense has been chosen for this groundbreaking research. It signifies the scientific relevance of EIS in understanding skin barrier functions. This moment represents a pivotal advancement in the application of our technology for skin health research."

Conclusion

The THREAT study exemplifies how collaboration can lead to innovative outcomes, especially in the field of dermatology. By leveraging SciBase’s EIS technology, researchers hope to illuminate the effects of daily environmental exposures on skin health, contributing significantly to dermatological studies. The findings from this initiative are anticipated to not only enhance the understanding of skin barrier function but also potentially influence future product formulations across the skincare industry, creating a ripple effect in both research and consumer practices.

In light of these developments, the scientific community and consumers alike will be keenly observing the results from the THREAT study as they unfold over time. For more detailed information about the study and its implications, readers are encouraged to explore the published editorial in the journal Allergy detailing the study’s design and anticipated outcomes.